Paxbp1 restrains cytotoxic and innate cell programs in CD4+ T cells to promote Th2 differentiation
Danielle A. Chisolm(National Institutes of Health), John J. O’Shea(National Institutes of Health)
Cited by 0
Related Papers
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
|The Journal of Immunology|2011|634